Your browser doesn't support javascript.
loading
Potential therapeutic applications of circular RNA in acute kidney injury.
Li, Zheng; Xing, Jihong.
Affiliation
  • Li Z; Department of Emergency Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
  • Xing J; Department of Emergency Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China. Electronic address: xingjh@jlu.edu.cn.
Biomed Pharmacother ; 174: 116502, 2024 May.
Article in En | MEDLINE | ID: mdl-38569273
ABSTRACT
Acute kidney injury (AKI) is a common clinical syndrome characterized by a rapid deterioration in renal function, manifested by a significant increase in creatinine and a sharp decrease in urine output. The incidence of morbidity and mortality associated with AKI is on the rise, with most patients progressing to chronic kidney disease or end-stage renal disease. Treatment options for patients with AKI remain limited. Circular RNA (circRNA) is a wide and diverse class of non-coding RNAs that are present in a variety of organisms and are involved in gene expression regulation. Studies have shown that circRNA acts as a competing RNA, is involved in disease occurrence and development, and has potential as a disease diagnostic and prognostic marker. CircRNA is involved in the regulation of important biological processes, including apoptosis, oxidative stress, and inflammation. This study reviews the current status and progress of circRNA research in the context of AKI.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / RNA, Circular Limits: Animals / Humans Language: En Journal: Biomed Pharmacother Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Kidney Injury / RNA, Circular Limits: Animals / Humans Language: En Journal: Biomed Pharmacother Year: 2024 Document type: Article